Hypothesis: Roux-en-Y reconstruction (RYR) is associated with a reduction in morbidity and mortality associated with pancreatic anastomotic failure after pancreaticoduodenectomy compared with conventional loop reconstruction (CLR).
P ANCREATICODUODENECTOMY is associated with a high rate of postoperative complications and morbidity. [1] [2] [3] [4] [5] Pancreatic anastomotic failure remains among the most common and potentially lethal postoperative complications of pancreaticoduodenectomy. 5, 6 Patients with pancreatic anastomotic failure may require subsequent operation or postoperative interventional radiology drainage procedures. 4, 7 Mortality is reported in association with postoperative pancreatic failure, although the associated mortality rate has decreased in recent years. 5, 6 There has been long-standing interest in the development of techniques to reduce the rate of pancreatic anastomotic leakage 1, 4, [8] [9] [10] [11] and its associated morbidity. 12, 13 Use of a Roux-en-Y loop for reconstruction (RYR) of pancreatic drainage is a technique that has been suggested to reduce pancreatic anastomotic leak-related mor-bidity and mortality in patients undergoing pancreaticoduodenectomy. [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] It has been suggested that isolation of the pancreatic anastomosis from the biliary and gastric anastomoses prevents activation of the secreted inactive precursor pancreatic enzymes by low gastric pH or enterokinase. 14, 15, 18, 19 This, it has been suggested, results in lower morbidity and mortality rates in the setting of pancreatic anastomotic failure 19 because inactive pancreatic enzyme precursors are not associated with "serious complications." 15 Kingsnorth 18 has referred to pancreatic anastomotic failure after RYR as "relatively benign."
In this report, we describe a large singleinstitutional experience with the use of a Roux-en-Y limb for pancreatic reconstruction after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. The results are presented in the context of a series of patients who underwent a stan-dard reconstruction after pancreaticoduodenectomy during the same period. The goal of this study was to determine whether RYR is associated with better overall outcomes and with better outcomes among the subset of patients who have pancreatic anastomotic failure after pancreaticoduodenectomy. 
METHODS

Patients undergoing pancreaticoduodenectomy for pancreatic ductal adenocarcinoma between
SURGICAL CONDUCT
The operations in this series were performed by 16 different surgical oncologists. The number of cases per surgeon ranged from 1 to 216. The choice of reconstructive technique (RYR or CLR) was based on the decision of the operating surgeon. No data on factors leading to the decision to perform RYR or CLR were available in this retrospective study. The technique of pancreaticojejunal anastomosis was not standardized, and the choice of anastomosis was based on the decision of the operating surgeon. The use of pylorus-preserving procedures was not standardized. Anastomotic stenting of the pancreatic duct was not routinely used. Some patients in the series were participants in a randomized prospective trial of postoperative closed suction drainage. 4 In all other cases, drains were placed at the discretion of the attending surgeon. Octreotide acetate was not routinely used in the perioperative period.
DATA COLLECTED
Data on operative time (incision to skin closure, including diagnostic laparoscopy), estimated blood loss, length of stay, development of a pancreatic anastomotic failure, development of delayed gastric emptying, and requirement for a postoperative interventional radiology procedure were collected for each patient. Complete data on postoperative complications and length of stay were not available for all patients. For each analysis, patients on whom no data were available were excluded. For the purposes of this report, pancreatic anastomotic failure was defined as more than 50 mL of amylase-rich (Ͼ3 times the serum amylase activity) drainage on or after postoperative day 5 from a drain placed at the time of the operation or during the postoperative period by interventional radiology or anastomotic leakage requiring subsequent operation. Delayed gastric emptying was defined as the requirement for replacement of a nasogastric tube on or after postoperative day 10 in the absence of an intra-abdominal collection or evidence of a smallbowel obstruction. 
STATISTICAL ANALYSIS
RESULTS
DEMOGRAPHIC AND OPERATIVE PROCEDURES
Seven hundred patients who underwent a pancreaticoduodenectomy for pancreatic ductal adenocarcinoma were identified for analysis. One hundred twelve patients underwent RYR after pancreaticoduodenectomy. Of those who underwent RYR, 12 had an isolated Roux limb to the pancreas (Figure, A) and 100 had a Roux limb to the pancreas and bile duct (Figure, B) . Five hundred eightyeight underwent CLR (Figure, C) .
The median age of patients in the series was 69 years (range, 36-90 years). No difference was found in the median age of patients in the 2 groups (RYR, 68 years [range, 36-83 years] vs CLR, 70 years [range, 38-90 years]; P=.32). A significant difference was found in the sex distribution of patients in the 2 groups (RYR, 62.5% female vs CLR, 51.1% female; P = .03).
No difference was seen in the rate of use of RYR during the period studied (1991-1995, 14.0%; 1996-2000, 13.7%; and 2001-2006, 18.7%; P=.20) . Nine of 16 surgeons used RYR at least once. The rate of use of RYR among the surgeons ranged from 0% to 90%.
OPERATIVE RESULTS
The median operative time for all patients in this series was 5.2 hours (range, 1.8-11.7 hours). Median operating time varied significantly by surgeon (P =.004). Median operative time was significantly longer in the RYR group ( 
POSTOPERATIVE RESULTS
No difference was found in the rate of interventional radiology drainage procedures required (RYR, 9.8% vs CLR, 6.8%; P = .24) or the rate of subsequent operation required (RYR, 9.1% vs CLR, 6.9%; P=.62). The median length of hospital stay among patients who survived the perioperative period was significantly shorter in the patients undergoing CLR (10 days [range, 5-72 days]) compared with those undergoing RYR (11 days [range, 5-52 days]) (P =.003). The overall rate of postoperative pancreatic anastomotic failure was 7.2%. No significant difference was observed in the rates of pancreatic anastomotic failure comparing surgeons in this study (P=.26). Pancreatic anastomotic failure was significantly more common in the patients undergoing RYR (14.8%) compared with those undergoing CLR (5.7%) (P=.002). The length of hospital stay was similar among patients who developed a pancreatic fistula (CLR, 18 days [range, 10-66 days] vs RYR, 19 days [range, 9-52 days]; P =.98). No difference was found in the rate of delayed gastric emptying in the 2 groups (CLR, 10.3% vs RYR, 10.1%; P =.99).
The overall postoperative mortality rate in the present series was 2.3%. No statistically significant difference was seen in the rate of postoperative mortality comparing the 2 groups (CLR, 2.6% vs RYR, 0.9%; P=.54). The causes of postoperative mortality of patients in this series were as follows: cardiac arrest (n=6 [38%]), sepsis or multiple organ dysfunction (n=4 [25%]), pancreatic fistula (n=3 [19%]), hemorrhage or disseminated intravascular coagulation (n=12 [22%]), and portal vein thrombosis (n=1 [6%]). No statistically significant difference was found in the percentage of pancreatic leaks associated with mortality in the 2 groups (CLR, 9.4% [3 of 32] vs RYR, 0% [0 of 16]; P=.54). The comparison between postoperative morbidity and mortality in the 2 groups is summarized in the Table. COMMENT Pancreatic anastomotic failure has been and remains a significant source of morbidity for patients undergoing pancreaticoduodenectomy. 6, 25 As a result, numerous strat- egies have been investigated in an effort to reduce the rate of pancreatic anastomotic leakage. The technique of pancreaticojejunal anastomosis, 8 use of pancreaticogastrostomy, 9 occlusion of the pancreatic duct, 10 stenting of the pancreatic duct, 26 use of postoperative octreotide acetate, 1 avoidance of closed suction surgical drains, 4 and maintenance of good blood supply to the pancreatic remnant 11 have been concepts previously studied in an effort to reduce the rate and severity of pancreatic anastomotic leaks. Use of RYR for pancreatic drainage after pancreaticoduodenectomy has been suggested to reduce the morbidity associated with pancreatic anastomotic failure. 14, 15, 18, 19 Use of RYR after pancreaticoduodenectomy was popularized by Machado et al. 14 To our knowledge, no prospective randomized studies have been performed on the value of RYR of the pancreas after pancreaticoduodenectomy. Several case series have reported a reduction in the rate of pancreatic anastomotic leakage and mortality associated with pancreatic anastomotic leakage compared with historical controls. [14] [15] [16] [17] [18] [19] [21] [22] [23] [24] 27 In these series the RYR of the limb was used for reconstruction of pancreatic drainage 14, 15, [17] [18] [19] [21] [22] [23] 27 or both pancreatic and biliary drainage. 15, 16, 24 Most of these series suffer from small sample size 14, 16, 17, 19, 24, 27 and lack appropriate controls, limiting the value of their conclusions. One other series 15 has similarly compared outcomes among patients treated at a single institution. In that series, a difference was not found in pancreatic anastomotic leakage rate or leak-associated mortality rate comparing RYR and CLR techniques.
The present series does not support the concept that RYR is associated with less postoperative morbidity than CLR after pancreaticoduodenectomy even in the setting of pancreatic anastomotic failure. It is noteworthy that there was no mortality among RYR patients with pancreatic anastomotic failure; however, this finding was not statistically different from the mortality among CLR patients with pancreatic anastomotic failure (Table) . The length of hospital stay was not statistically different among those with pancreatic anastomotic failure comparing patients undergoing CLR with those undergoing RYR.
The overall rate of pancreatic anastomotic failure (7.2%) in the present series is in accordance with other modern series. 5, 6 In the present series, patients who underwent RYR had a higher rate of pancreatic anastomotic leakage than those undergoing CLR. This finding likely represents a selection bias toward selection of RYR for those at high risk for pancreatic anastomotic leakage (eg, small pancreatic duct and soft texture of the pancreas). Accurate information on pancreatic texture and duct size could not be collected in this retrospective series. The patients undergoing RYR had longer operative times, which may be related to differences in surgeon operative times because the use of RYR varied greatly among surgeons. No overall significant difference was found in the rate of postoperative mortality comparing the 2 groups (CLR vs RYR). The incidence of mortality related to pancreatic fistula in the entire series was low (0.4%), and the mortality associated with pancreatic anastomotic failure was 6%.
The present study has several limitations. It was a retrospective study and not a randomized trial. Pancreatic texture and pancreatic duct size, 2 of the factors known to be most commonly associated with an increased rate of pancreatic anastomotic leakage, could not be analyzed in this series. A meaningful comparison between use of the Roux limb for pancreatic reconstruction vs pancreatic and biliary reconstruction is not possible in the present series given the small sample size in the former group. Finally, this series contains patients with pancreatic ductal adenocarcinoma, and the findings may not be applicable to other histologic types of tumors.
It remains possible that use of a Roux limb improves long-term postoperative quality of life in patients undergoing pancreaticoduodenectomy by reducing the incidence of postoperative bile reflux and gastritis. 16, 27 This issue has not been addressed in the present study. Such a question could only be evaluated effectively in a prospective fashion.
In conclusion, we find that use of pancreaticobiliary RYR after pancreaticoduodenectomy is not associated with significantly improved outcomes, even among patients who develop pancreatic anastomotic failure. The widespread use of RYR in preference to CLR after pancreaticoduodenectomy is not supported.
